All News #Library
Biotech
IgGenix Completes Enrollment for IGNX001 Phase 1 Trial in Peanut
02 Sep 2025 //
PHARMAWEB
IgGenix Doses First Patient In Peanut Allergy Trial
16 Oct 2024 //
PR NEWSWIRE
IgGenix`s IGNX001 Shows Peanut Allergy Potential Ahead Of Clinical Trial
03 Jun 2024 //
PR NEWSWIRE
IgGenix Announces Patent Granted Covering Allergen-specific Antibodies
04 Apr 2023 //
BUSINESSWIRE

Market Place
Sourcing Support